These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12406541)

  • 1. Cellular mechanisms targeted during astrocytoma progression.
    Collins VP
    Cancer Lett; 2002 Dec; 188(1-2):1-7. PubMed ID: 12406541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology and molecular genetics of astrocytic gliomas.
    Reifenberger G; Collins VP
    J Mol Med (Berl); 2004 Oct; 82(10):656-70. PubMed ID: 15316624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gemistocytic astrocytomas].
    Matsko DE; Zrelov AA; Ulitin AY; Matsko MV; Skliar SS; Baksheeva AO; Imyanitov EN
    Arkh Patol; 2018; 80(4):27-38. PubMed ID: 30059069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression as exemplified by human astrocytic tumors.
    Collins VP
    Semin Cancer Biol; 1999 Aug; 9(4):267-76. PubMed ID: 10448114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative transcriptomics reveals similarities and differences between astrocytoma grades.
    Seifert M; Garbe M; Friedrich B; Mittelbronn M; Klink B
    BMC Cancer; 2015 Dec; 15():952. PubMed ID: 26673168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gliomas.
    Collins VP
    Cancer Surv; 1998; 32():37-51. PubMed ID: 10489622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
    Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification and biology of astrocytic gliomas.
    Schiffer D
    Forum (Genova); 1998; 8(3):244-55. PubMed ID: 9755290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome analysis reveals distinct gene expression profiles in astrocytoma grades II-IV.
    Narsia N; Ramagiri P; Ehrmann J; Kolar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):261-271. PubMed ID: 28452381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grading astrocytomas.
    Adelman LS
    Neurosurg Clin N Am; 1994 Jan; 5(1):35-41. PubMed ID: 8124092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathogenesis of astrocytoma and glioblastoma multiforme.
    Van de Kelft E
    Acta Neurochir (Wien); 1997; 139(7):589-99. PubMed ID: 9265950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis.
    MacDonald TJ; Pollack IF; Okada H; Bhattacharya S; Lyons-Weiler J
    Methods Mol Biol; 2007; 377():203-22. PubMed ID: 17634619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Classification of the astrocytic gliomas. Brief comments].
    Pérez-Ortiz L; Galarraga J; Gómez-Suárez H; Tamayo-Suárez JD
    Rev Neurol; 2000 Dec 16-31; 31(12):1180-3. PubMed ID: 11205555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignancy grading of glial tumors. I. Astrocytomas].
    Martin H; Schmidt D
    Zentralbl Allg Pathol; 1985; 130(6):451-62. PubMed ID: 3010600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular pathology of brain tumors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2005; 122(1):191-6. PubMed ID: 16173698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression.
    Comincini S; Facoetti A; Del Vecchio I; Peoc'h K; Laplanche JL; Magrassi L; Ceroni M; Ferretti L; Nano R
    Anticancer Res; 2004; 24(3a):1507-17. PubMed ID: 15274317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas].
    Yamada SM; Bruner JM; Berger MS; Morrison RS
    No To Shinkei; 1996 Apr; 48(4):363-70. PubMed ID: 8679334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
    Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
    Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reclassification of oligoastrocytomas by loss of heterozygosity studies.
    Eoli M; Bissola L; Bruzzone MG; Pollo B; Maccagnano C; De Simone T; Valletta L; Silvani A; Bianchessi D; Broggi G; Boiardi A; Finocchiaro G
    Int J Cancer; 2006 Jul; 119(1):84-90. PubMed ID: 16432842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.